Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Progesterone impairs Herceptin effect on breast cancer cells.

Kitowska K, Kowalska A, Mieszkowska M, Piasecka D, Skladanowski AC, Romanska HM, Sadej R.

Oncol Lett. 2018 Feb;15(2):1817-1822. doi: 10.3892/ol.2017.7493. Epub 2017 Nov 27.

2.

Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells.

Lica JJ, Grabe GJ, Heldt M, Misiak M, Bloch P, Serocki M, Switalska M, Wietrzyk J, Baginski M, Hellmann A, Borowski E, Skladanowski A.

Stem Cells Dev. 2018 Apr 1;27(7):488-513. doi: 10.1089/scd.2017.0245. Epub 2018 Mar 13.

PMID:
29431006
3.

Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.

Misiak M, Heldt M, Szeligowska M, Mazzini S, Scaglioni L, Grabe GJ, Serocki M, Lica J, Switalska M, Wietrzyk J, Beretta GL, Perego P, Zietkowski D, Baginski M, Borowski E, Skladanowski A.

Oncotarget. 2017 Oct 10;8(62):105137-105154. doi: 10.18632/oncotarget.21806. eCollection 2017 Dec 1.

4.

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.

Turczyk L, Kitowska K, Mieszkowska M, Mieczkowski K, Czaplinska D, Piasecka D, Kordek R, Skladanowski AC, Potemski P, Romanska HM, Sadej R.

Neoplasia. 2017 Oct;19(10):791-804. doi: 10.1016/j.neo.2017.07.006. Epub 2017 Sep 1.

5.

Tetraspanin CD151 mediates communication between PC3 prostate cancer cells and osteoblasts.

Grudowska A, Czaplińska D, Polom W, Matuszewski M, Sądej R, Składanowski AC.

Acta Biochim Pol. 2017;64(1):135-141. doi: 10.18388/abp.2016_1356. Epub 2017 Mar 14.

6.

Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.

Daśko M, Przybyłowska M, Rachon J, Masłyk M, Kubiński K, Misiak M, Składanowski A, Demkowicz S.

Eur J Med Chem. 2017 Mar 10;128:79-87. doi: 10.1016/j.ejmech.2017.01.028. Epub 2017 Jan 22.

PMID:
28152429
7.

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells.

Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, Skladanowski AC, Zaczek AJ, Biernat W, Kordek R, Romanska HM, Sadej R.

Oncotarget. 2016 Dec 27;7(52):86011-86025. doi: 10.18632/oncotarget.13322.

8.

Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.

Czaplinska D, Mieczkowski K, Supernat A, Skladanowski AC, Kordek R, Biernat W, Zaczek AJ, Romanska HM, Sadej R.

Tumour Biol. 2016 Oct;37(10):13721-13731. Epub 2016 Jul 30.

9.

Influence of S-Oxidation on Cytotoxic Activity of Oxathiole-Fused Chalcones.

Konieczny MT, Buɬakowska A, Pirska D, Konieczny W, Skladanowski A, Sabisz M, Wojciechowski M, Lemke K.

Chem Biol Drug Des. 2016 Oct;88(4):519-33. doi: 10.1111/cbdd.12776. Epub 2016 May 20.

PMID:
27198732
10.

Erratum to "Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation" [Eur. J. Med. Chem. 106 (2015) 85-94].

Januchta W, Serocki M, Dzierzbicka K, Cholewiński G, Skladanowski A.

Eur J Med Chem. 2016 Jun 30;116:318-319. doi: 10.1016/j.ejmech.2016.02.067. Epub 2016 May 10. No abstract available.

PMID:
27177783
11.

Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.

Koszałka P, Gołuńska M, Urban A, Stasiłojć G, Stanisławowski M, Majewski M, Składanowski AC, Bigda J.

PLoS One. 2016 Mar 10;11(3):e0151420. doi: 10.1371/journal.pone.0151420. eCollection 2016.

12.

[Aspects of progesterone receptor (PR) activity regulation - impact on breast cancer progression].

Piasecka D, Składanowski AC, Kordek R, Romańska HM, Sądej R.

Postepy Biochem. 2015;61(2):198-206. Review. Polish.

13.

CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.

Koszałka P, Gołuńska M, Stanisławowski M, Urban A, Stasiłojć G, Majewski M, Wierzbicki P, Składanowski AC, Bigda J.

Int J Biochem Cell Biol. 2015 Dec;69:1-10. doi: 10.1016/j.biocel.2015.10.003. Epub 2015 Oct 13.

PMID:
26545615
14.

Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation.

Januchta W, Serocki M, Dzierzbicka K, Cholewiński G, Skladanowski A.

Eur J Med Chem. 2015 Dec 1;106:85-94. doi: 10.1016/j.ejmech.2015.10.012. Epub 2015 Oct 21. Erratum in: Eur J Med Chem. 2016 Jun 30;116:318-319.

PMID:
26520842
15.

Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin.

Konieczny MT, Buɬakowska A, Pirska D, Konieczny W, Skladanowski A, Sabisz M, Wojciechowski M, Lemke K, Pieczykolan A, Strożek W.

Eur J Med Chem. 2015 Jan 7;89:733-42. doi: 10.1016/j.ejmech.2014.10.075. Epub 2014 Oct 30.

PMID:
25462279
16.

Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.

Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska AD, Skladanowski AC, Zaczek AJ, Romanska HM, Sadej R.

Biochim Biophys Acta. 2014 Nov;1843(11):2461-70. doi: 10.1016/j.bbamcr.2014.06.022. Epub 2014 Jul 8.

17.

Structural factors affecting cytotoxic activity of (E)-1-(Benzo[d ][1,3]oxathiol-6-yl)-3-phenylprop-2-en-1-one derivatives.

Konieczny MT, Bułakowska A, Polak J, Pirska D, Konieczny W, Gryń P, Skladanowski A, Sabisz M, Lemke K, Pieczykolan A, Gałązka M, Wiciejowska K, Wietrzyk J.

Chem Biol Drug Des. 2014 Jul;84(1):86-91. doi: 10.1111/cbdd.12296. Epub 2014 Feb 28.

PMID:
24476543
18.
19.

Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.

Koszałka P, Pryszlak A, Gołuńska M, Kolasa J, Stasiłojć G, Składanowski AC, Bigda JJ.

Oncol Rep. 2014 Feb;31(2):819-27. doi: 10.3892/or.2013.2883. Epub 2013 Nov 29.

PMID:
24297662
20.
21.
22.

PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells.

Węsierska-Gądek J, Zulehner N, Ferk F, Składanowski A, Komina O, Maurer M.

Biochem Pharmacol. 2012 Nov 15;84(10):1318-31. doi: 10.1016/j.bcp.2012.07.024. Epub 2012 Aug 14.

23.

Novel approaches in the synthesis of batracylin and its analogs: rebirth of an old player?

Dzierzbicka K, Januchta W, Skladanowski A.

Curr Med Chem. 2012;19(26):4475-87. Review.

PMID:
22830346
24.

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers.

Adar Y, Stark M, Bram EE, Nowak-Sliwinska P, van den Bergh H, Szewczyk G, Sarna T, Skladanowski A, Griffioen AW, Assaraf YG.

Cell Death Dis. 2012 Apr 5;3:e293. doi: 10.1038/cddis.2012.30.

25.

Therapeutic intervention by the simultaneous inhibition of DNA repair and type I or type II DNA topoisomerases: one strategy, many outcomes.

Węsierska-Gądek J, Składanowski A.

Future Med Chem. 2012 Jan;4(1):51-72. doi: 10.4155/fmc.11.175. Review.

PMID:
22168164
26.

Induction of the multixenobiotic/multidrug resistance system in HeLa cells in response to imidazolium ionic liquids.

Rusiecka I, Składanowski AC.

Acta Biochim Pol. 2011;58(2):187-92. Epub 2011 May 17.

27.

Solid phase synthesis and biological activity of tuftsin conjugates.

Kukowska-Kaszuba M, Dzierzbicka K, Serocki M, Skladanowski A.

J Med Chem. 2011 Apr 14;54(7):2447-54. doi: 10.1021/jm200002s. Epub 2011 Mar 22.

PMID:
21425770
28.
29.

Mechanism of cytotoxic action of perfluorinated acids. III. Disturbance in Ca²+ homeostasis.

Kleszczyński K, Składanowski AC.

Toxicol Appl Pharmacol. 2011 Mar 1;251(2):163-8. doi: 10.1016/j.taap.2011.01.002. Epub 2011 Jan 12.

PMID:
21236286
30.

H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy.

Podhorecka M, Skladanowski A, Bozko P.

J Nucleic Acids. 2010 Aug 3;2010. pii: 920161. doi: 10.4061/2010/920161.

31.
33.

DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.

Skladanowski A, Bozko P, Sabisz M.

Chem Rev. 2009 Jul;109(7):2951-73. doi: 10.1021/cr900026u. Review. No abstract available.

PMID:
19522503
34.

Structural determinants of imidazoacridinones facilitating antitumor activity are crucial for substrate recognition by ABCG2.

Bram EE, Adar Y, Mesika N, Sabisz M, Skladanowski A, Assaraf YG.

Mol Pharmacol. 2009 May;75(5):1149-59. doi: 10.1124/mol.109.054791. Epub 2009 Feb 27.

PMID:
19251825
35.

Mechanism of cytotoxic action of perfluorinated acids II. Disruption of mitochondrial bioenergetics.

Kleszczyński K, Stepnowski P, Składanowski AC.

Toxicol Appl Pharmacol. 2009 Mar 1;235(2):182-90. doi: 10.1016/j.taap.2008.11.021. Epub 2008 Dec 16.

PMID:
19135466
36.

Mechanism of cytotoxic action of perfluorinated acids. I. alteration in plasma membrane potential and intracellular pH level.

Kleszczyński K, Składanowski AC.

Toxicol Appl Pharmacol. 2009 Feb 1;234(3):300-5. doi: 10.1016/j.taap.2008.10.008. Epub 2008 Nov 5.

PMID:
19026671
37.

Simplex-optimized chromatographic resolution of selected ionic liquid cations utilizing a polar reversed-phase system.

Nichthauser J, Paszkiewicz M, Składanowski AC, Stepnowski P.

Anal Sci. 2008 Oct;24(10):1355-8.

38.
39.

The influence of G(2) arrest abrogation on the long-term cytotoxicity of different genotoxic lesions.

Bozko P, Larsen AK, Skladanowski A.

Cell Cycle. 2008 Jun 15;7(12):1880-3. Epub 2008 Jun 7. No abstract available.

PMID:
18583927
40.
41.

Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.

Sadej R, Inai K, Rajfur Z, Ostapkowicz A, Kohler J, Skladanowski AC, Mitchell BS, Spychala J.

Biochim Biophys Acta. 2008 Jan;1782(1):35-40. Epub 2007 Nov 13.

42.

Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling: implications for cancer therapy.

Skladanowski A, Bozko P, Sabisz M, Larsen AK.

Cell Cycle. 2007 Sep 15;6(18):2268-75. Epub 2007 Jul 5.

PMID:
17890906
43.

Analysis of structure-cytotoxicity in vitro relationship (SAR) for perfluorinated carboxylic acids.

Kleszczyński K, Gardzielewski P, Mulkiewicz E, Stepnowski P, Składanowski AC.

Toxicol In Vitro. 2007 Sep;21(6):1206-11. Epub 2007 May 10.

PMID:
17572060
44.

C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.

Bram EE, Ifergan I, Grimberg M, Lemke K, Skladanowski A, Assaraf YG.

Biochem Pharmacol. 2007 Jun 30;74(1):41-53. Epub 2007 Apr 1.

PMID:
17481587
45.

Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line.

Konieczny MT, Konieczny W, Sabisz M, Skladanowski A, Wakieć R, Augustynowicz-Kopeć E, Zwolska Z.

Chem Pharm Bull (Tokyo). 2007 May;55(5):817-20.

46.

Evaluation of the acute toxicity of perfluorinated carboxylic acids using eukaryotic cell lines, bacteria and enzymatic assays.

Mulkiewicz E, Jastorff B, Składanowski AC, Kleszczyński K, Stepnowski P.

Environ Toxicol Pharmacol. 2007 May;23(3):279-85. doi: 10.1016/j.etap.2006.11.002. Epub 2006 Nov 12.

PMID:
21783770
47.

Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.

Konieczny MT, Konieczny W, Sabisz M, Skladanowski A, Wakieć R, Augustynowicz-Kopeć E, Zwolska Z.

Eur J Med Chem. 2007 May;42(5):729-33. Epub 2007 Jan 9.

PMID:
17300856
48.

Ecto-5'-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells.

Sadej R, Spychala J, Skladanowski AC.

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1119-23.

PMID:
17065075
49.

Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases.

Borowiec A, Lechward K, Tkacz-Stachowska K, Składanowski AC.

Acta Biochim Pol. 2006;53(2):269-78. Epub 2006 Jun 12. Review.

50.

Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.

Sadej R, Spychala J, Skladanowski AC.

Melanoma Res. 2006 Jun;16(3):213-22.

PMID:
16718268

Supplemental Content

Loading ...
Support Center